A Scalable IHC approach for Clinical & Research uses

At OligGmark we are pioneering continuous/unlimited immunohistochemistry detection through proprietary technologies.

Discover connections between targets of interest in the same specimen slide, gain reliability of target co-occurrence, and develop large-scale targeted IHC panels akin to targeted-DNA sequencing. Our goal is to expand biomarker capabilities by helping you gain deep insights from valuable specimens that have been under-utilized until now.